Kathleen Sereda Glaub - 04 Nov 2021 Form 4 Insider Report for IO Biotech, Inc. (IOBT)

Role
Director
Signature
/s/ Brian Burkavage, Attorney-in-Fact for Kathleen Sereda Glaub
Issuer symbol
IOBT
Transactions as of
04 Nov 2021
Net transactions value
$0
Form type
4
Filing time
08 Nov 2021, 17:39:23 UTC
Next filing
31 May 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IOBT Stock Option (Right to Buy) Award $0 +21,295 $0.000000 21,295 04 Nov 2021 Common Stock 21,295 $14.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These options vest annually over three years from the vesting commencement date of November 4, 2021, subject to the reporting person's continued service through the applicable vesting date, and subject to 100% acceleration upon a change of control.